Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leverger

Showing results (341-350 of 434) with videos related to

Pageof 44
Sort By:
British Journal of Haematology|March 5, 2020
Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 yearsStéphane Ducassou, Anne Gourdonneau, Helder Fernandes, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2021
Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendationsMaxime Enault, Véronique Minard-Colin, Nadège Corradini, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Haematologica|July 10, 2025
Ovarian tissue autotransplantation in acute leukemia: balancing the risk of relapse and the hope of parenthoodFlorian Chevillon, Elsa Labrune, Emmanuelle Clappier, et al.
Blood|October 21, 2017
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemiaArnaud Petit, Amélie Trinquand, Sylvie Chevret, et al.
Pediatric Blood & Cancer|August 17, 2020
Quality of life in parents of childhood leukemia survivors. A French Childhood Cancer Survivor Study for Leukemia studyCamille Vercasson, Pascal Auquier, Gérard Michel, et al.
Hemasphere|January 18, 2021
Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents StudyMarie-Dominique Tabone, Sami Kolta, Pascal Auquier, et al.
Hemasphere|November 15, 2019
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study GroupAlice Marceau-Renaut, Nicolas Duployez, Benoît Ducourneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde EnfantYves Perel, Anne Auvrignon, Thierry Leblanc, et al.
Pageof 44

Showing results (341-350 of 434) with videos related to

Sort By:
Pageof 44
British Journal of Haematology|March 5, 2020
Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 yearsStéphane Ducassou, Anne Gourdonneau, Helder Fernandes, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2021
Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendationsMaxime Enault, Véronique Minard-Colin, Nadège Corradini, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Haematologica|July 10, 2025
Ovarian tissue autotransplantation in acute leukemia: balancing the risk of relapse and the hope of parenthoodFlorian Chevillon, Elsa Labrune, Emmanuelle Clappier, et al.
Blood|October 21, 2017
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemiaArnaud Petit, Amélie Trinquand, Sylvie Chevret, et al.
Pediatric Blood & Cancer|August 17, 2020
Quality of life in parents of childhood leukemia survivors. A French Childhood Cancer Survivor Study for Leukemia studyCamille Vercasson, Pascal Auquier, Gérard Michel, et al.
Hemasphere|January 18, 2021
Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents StudyMarie-Dominique Tabone, Sami Kolta, Pascal Auquier, et al.
Hemasphere|November 15, 2019
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study GroupAlice Marceau-Renaut, Nicolas Duployez, Benoît Ducourneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde EnfantYves Perel, Anne Auvrignon, Thierry Leblanc, et al.
Pageof 44